Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Skip the complicated regimens and expensive products seen on social media. The science of skin is deep but the ...

Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial approval, data from pancreatic cancer trials presented at ASCO GI Symposium, and ...

The South Jersey biotech also secured a $22 million ARPA-H grant and additional investment to advance its research on therapies targeting aging.

Medicus Pharma (NASDAQ:MDCX) said on Monday that new analysis of data from a mid-stage clinical trial of its SkinJect ...

A clinical trial found nicotinamide, a form of vitamin B3, may help reduce skin cancer risk. Participants who took ...

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported topline results from a Phase 2 clinical trial evaluating a ...

Doctors are offering possible reasons for President Donald Trump's visible neck irritation, which was noticed by the public during a Medal of Honor Ceremony at the White House on Sunday.

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

The White House said the president is using a common cream as preventative skin treatment, but did not provide specifics.

A former reality television star has spoken out about a recent health scare. Teddi Mellencamp revealed that she was recently ...

The study explores the neoadjuvant approach: administering the immunotherapy drug Keytruda (pembrolizumab) before a surgeon ever picks up a scalpel. Researchers observed dramatic tumor shrinkage and, ...